• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Coordination of Patient Care in and out of ACOs

Video

Patients who are members of an ACO are not likely to realize it, comments Dennis Scanlon, PhD, Summit moderator. He asks how providers can keep ACO members within the system, avoiding care providers who do not have the same incentives. Ateev Mehrotra, MD, MPH, associate professor of healthcare policy and medicine at Harvard Medical School, and a hospitalist at Beth Israel Deaconess Medical Center, agrees that patients probably do not know what type of system it is or the incentives being used within their ACO.

Coordination of care among any providers (within or outside of the system) improves quality, insists Arthur Vercillo, MD, FACS, a surgeon and regional president of Excellus Blue Cross Blue Shield. This is true of the sickest patients who utilize many services and those members who occasionally use the healthcare system.

Dr Scanlon points out that health information technology is supposed to help in this regard, and legislation (eg, the HITECH Act) and resources have been directed toward improving the utilization of HIT. Yet, he says, “I think critics would say this concept of ‘meaningful use’ has been anything but meaningful in terms of how HIT is being used…all of the investment we’ve made in HIT isn’t sort of moving us in that direction.”

Dr Vercillo notes that the money spent on HIT, the formation of regional health information organizations, “is supposed to reduce redundancy. Empirically, it makes so much sense, but so far, we’re having a hard time proving the ROI is there.”


Related Videos
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Jo Varshney, PhD, DVM, CEO and founder of VeriSIM Life
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Adam Brufsky, MD, PhD, University of Pittsburgh
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, assistant professor in the department of integrative translational sciences at City of Hope
Dr Marco Del Riccio
Dr Steven Manobianco
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.